Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6555)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 24, 2023 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rocha Pinheiro SL, Lemos FFB, Marques HS, Silva Luz M, de Oliveira Silva LG, Faria Souza Mendes dos Santos C, da Costa Evangelista K, Calmon MS, Sande Loureiro M, Freire de Melo F. Immunotherapy in glioblastoma treatment: Current state and future prospects. World J Clin Oncol 2023; 14(4): 138-159 [PMID: 37124134 DOI: 10.5306/wjco.v14.i4.138] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i4/138.htm |
| Number | Citing Articles |
| 1 |
Anna Galicka, Łukasz Szoka, Iwona Radziejewska, Cezary Marcinkiewicz. Effect of Dimeric Disintegrins Isolated from Vipera lebetina obtusa Venom on Glioblastoma Cellular Responses. Cancers 2023; 15(19): 4805 doi: 10.3390/cancers15194805
|
| 2 |
Jan Patrick Formanski, Hai Dang Ngo, Vivien Grunwald, Celine Pöhlking, Jana Sue Jonas, Dominik Wohlers, Birco Schwalbe, Michael Schreiber. Transduction Efficiency of Zika Virus E Protein Pseudotyped HIV-1gfp and Its Oncolytic Activity Tested in Primary Glioblastoma Cell Cultures. Cancers 2024; 16(4): 814 doi: 10.3390/cancers16040814
|
| 3 |
Augusto Müller Fiedler, Michelle Medeiros, Haidi Dalinda Fiedler. Targeted Glioblastoma Treatment via Synthesis and Functionalization of Gold Nanoparticles With De Novo–Engineered Transferrin-Like Peptides: Protocol for a Novel Method. JMIR Research Protocols 2023; 12: e49417 doi: 10.2196/49417
|
| 4 |
Hao Zhang, Ying Hong, Tingting Wu, Eyi Ben, Shuai Li, Liu Hu, Tao Xie. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1401967
|
| 5 |
Gagandeep Singh, Annie Singh, Joseph Bae, Sunil Manjila, Vadim Spektor, Prateek Prasanna, Angela Lignelli. New frontiers in domain-inspired radiomics and radiogenomics: increasing role of molecular diagnostics in CNS tumor classification and grading following WHO CNS-5 updates. Cancer Imaging 2024; 24(1) doi: 10.1186/s40644-024-00769-6
|
| 6 |
Tiffany M. Juarez, Jaya M. Gill, Boris R. Minev, Akanksha Sharma, Santosh Kesari. Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review. Critical Reviews in Oncology/Hematology 2025; 206: 104596 doi: 10.1016/j.critrevonc.2024.104596
|
| 7 |
Joanna Jazowiecka-Rakus, Kinga Pogoda-Mieszczak, Masmudur M. Rahman, Grant McFadden, Aleksander Sochanik. Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma. International Journal of Molecular Sciences 2024; 25(20): 11225 doi: 10.3390/ijms252011225
|
| 8 |
Pablo Shimaoka Chagas, Henrique Izumi Shimaoka Chagas, Sahar Emami Naeini, Bidhan Bhandari, Jules Gouron, Tathiane M. Malta, Évila Lopes Salles, Lei P. Wang, Jack C. Yu, Babak Baban. Network‐Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma. Journal of Cellular Biochemistry 2024; 125(8) doi: 10.1002/jcb.30612
|
| 9 |
Isacco Desideri, Valerio Nardone, Ilaria Morelli, Federico Gagliardi, Giuseppe Minniti. Advanced Imaging and Therapy in Neuro-Oncology. 2024; : 101 doi: 10.1007/978-3-031-59341-3_7
|
| 10 |
O. A. Beylerli, E. R. Musaev, A. A. Bukhvostov. Immunotherapy for Malignant Gliomas: Overcoming Barriers and Defining Prospects for Integrated Approaches. Creative surgery and oncology 2024; 14(4): 351 doi: 10.24060/2076-3093-2024-14-4-351-359
|
| 11 |
George B. H. Green, Alexis N. Cox-Holmes, Anna Claire E. Potier, Gillian H. Marlow, Braden C. McFarland. Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota. Biomedicines 2024; 12(11): 2429 doi: 10.3390/biomedicines12112429
|
| 12 |
Yu-Jen Lu, Reesha Kakkadavath Vayalakkara, Banendu Sunder Dash, Shang-Hsiu Hu, Thejas Pandaraparambil Premji, Chun-Yuan Wu, Yang-Jin Shen, Jyh-Ping Chen. Immunomodulatory R848-Loaded Anti-PD-L1-Conjugated Reduced Graphene Oxide Quantum Dots for Photothermal Immunotherapy of Glioblastoma. Pharmaceutics 2024; 16(8): 1064 doi: 10.3390/pharmaceutics16081064
|
| 13 |
Lisa Feldman. Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1384249
|
| 14 |
Lauren Michelle Webb, Mason J. Webb, Jian L. Campian, Samantha J. Caron, Michael W. Ruff, Joon H. Uhm, Ugur Sener. A case series of osseous metastases in patients with glioblastoma. Medicine 2024; 103(27): e38794 doi: 10.1097/MD.0000000000038794
|
| 15 |
А. А. Pichugin, R. R. Kovyazina, А. Trondin, А. G. Alekseev, P. B. Kopnin, T. V. Gessel, S. V. Boichuk. Immunotherapy of malignant gliomas: a modern view on the problem. Advances in Molecular Oncology 2024; 11(4): 23 doi: 10.17650/2313-805X-2024-11-4-23-40
|
| 16 |
Nasim Dana, Arezou Dabiri, Majed Bahri Najafi, Azadeh Rahimi, Sayed Mohammad Matin Ishaghi, Laleh Shariati, Minmin Shao, Assunta Borzacchiello, Ilnaz Rahimmanesh, Pooyan Makvandi. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy. Bioengineering & Translational Medicine 2024; doi: 10.1002/btm2.10716
|
| 17 |
Surjendu Maity, Tamanna Bhuyan, Christopher Jewell, Satoru Kawakita, Saurabh Sharma, Huu Tuan Nguyen, Alireza Hassani Najafabadi, Menekse Ermis, Natashya Falcone, Junjie Chen, Kalpana Mandal, Danial Khorsandi, Can Yilgor, Auveen Choroomi, Emily Torres, Marvin Mecwan, Johnson V. John, Mohsen Akbari, Zhaohui Wang, Diogo Moniz‐Garcia, Alfredo Quiñones‐Hinojosa, Vadim Jucaud, Mehmet Remzi Dokmeci, Ali Khademhosseini. Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications. Small 2025; 21(1) doi: 10.1002/smll.202405511
|
| 18 |
Manoj Kumar, Lauren C. Nassour-Caswell, Hasan Alrefai, Joshua C. Anderson, Taylor L. Schanel, Patricia H. Hicks, Rex Cardan, Christopher D. Willey. A High-Throughput Neurosphere-Based Colony Formation Assay to Test Drug and Radiation Sensitivity of Different Patient-Derived Glioblastoma Lines. Cells 2024; 13(23): 1995 doi: 10.3390/cells13231995
|
| 19 |
Prateek Jain, Shambhavi Vashist, Binay K Panjiyar. Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression. Cureus 2023; doi: 10.7759/cureus.46089
|
| 20 |
Thomas Eckert, M. S. Zobaer, Jessie Boulos, Angela Alexander-Bryant, Tiffany G. Baker, Charlotte Rivers, Arabinda Das, William A. Vandergrift, Jaime Martinez, Alicia Zukas, Scott M. Lindhorst, Sunil Patel, Ben Strickland, Nathan C. Rowland. Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy. Cancers 2025; 17(3): 462 doi: 10.3390/cancers17030462
|
| 21 |
Mohd Haseeb, Imran Khan, Zeynep Kartal, Sadaf Mahfooz, Mustafa Aziz Hatiboglu. Status Quo in the Liposome-Based Therapeutic Strategies Against Glioblastoma: “Targeting the Tumor and Tumor Microenvironment”. International Journal of Molecular Sciences 2024; 25(20): 11271 doi: 10.3390/ijms252011271
|
| 22 |
Karol Sadowski, Adrianna Jażdżewska, Jan Kozłowski, Aleksandra Zacny, Tomasz Lorenc, Wioletta Olejarz. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. International Journal of Molecular Sciences 2024; 25(11): 5774 doi: 10.3390/ijms25115774
|
| 23 |
Arunraj Tharamelveliyil Rajendran, Anoop Narayanan Vadakkepushpakath. Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery. Foods 2024; 13(17): 2812 doi: 10.3390/foods13172812
|
| 24 |
Garima Yadav, Ritu Kulshreshtha. Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment. Life Sciences 2024; 339: 122438 doi: 10.1016/j.lfs.2024.122438
|
| 25 |
Roshan Keshari, Mahima Dewani, Navneet Kaur, Girijesh Kumar Patel, Sumit Kumar Singh, Pranjal Chandra, Rajendra Prasad, Rohit Srivastava. Lipid Nanocarriers as Precision Delivery Systems for Brain Tumors. Bioconjugate Chemistry 2025; doi: 10.1021/acs.bioconjchem.5c00007
|
| 26 |
Chia-En Wong, Yu Chang, Pei-Wen Chen, Yan-Ta Huang, Yu-Cheng Chang, Cho-Han Chiang, Liang-Chao Wang, Po-Hsuan Lee, Chi-Chen Huang, Heng-Juei Hsu, Jung-Shun Lee. Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis. Journal of Neuro-Oncology 2024; 170(2): 253 doi: 10.1007/s11060-024-04798-w
|
| 27 |
Gaurvi Bijalwan, Abhishek Kumar Shrivastav, Sarita Mallik, Manish Kumar Dubey. Glioblastoma multiforme - a rare type of cancer: A narrative review. Cancer Research, Statistics, and Treatment 2024; 7(3): 340 doi: 10.4103/crst.crst_250_23
|
| 28 |
Jayant Singh Bhardwaj, Shivangi Paliwal, Gautam Singhvi, Rajeev Taliyan. Immunological challenges and opportunities in glioblastoma multiforme: A comprehensive view from immune system lens. Life Sciences 2024; 357: 123089 doi: 10.1016/j.lfs.2024.123089
|
| 29 |
Pooya Farhangnia, Hossein Khorramdelazad, Pouria Ghiaee, Soheil Rahmani Fard, Ali-Akbar Delbandi. . Interdisciplinary Cancer Research 2023; doi: 10.1007/16833_2023_186
|
| 30 |
Krishna Malhotra. Predictions of Viral-Immunotherapy Glioblastoma Patient Response and Progression using Deep Neural Networks Reveal Novel Biomarkers for Targeted Therapy. SSRN Electronic Journal 2024; doi: 10.2139/ssrn.4854377
|
| 31 |
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, Robert Rončević. Why Do Glioblastoma Treatments Fail?. Future Pharmacology 2025; 5(1): 7 doi: 10.3390/futurepharmacol5010007
|
| 32 |
Santino Caserta, Sebastiano Gangemi, Giuseppe Murdaca, Alessandro Allegra. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. International Journal of Molecular Sciences 2023; 24(14): 11544 doi: 10.3390/ijms241411544
|
| 33 |
Wenya He, Ningyang Wang, Yaping Wang, Mengyao Liu, Qian Qing, Qihang Su, Yan Zou, Yang Liu. Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma. Pharmaceutics 2024; 16(4): 482 doi: 10.3390/pharmaceutics16040482
|
| 34 |
Yingying Lyu, Chaxian Liu, Hao Lin, Haikun Song, Qiyuan Zhuang, Ankang Hu, Liang Chen, Hui Yang, Ying Mao. Nuclear translocation of nucleotide enzyme Phosphoglucomutase 2 governs DNA damage response and anti-tumor immunity. Heliyon 2024; 10(17): e36415 doi: 10.1016/j.heliyon.2024.e36415
|
| 35 |
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, Lorenzo Colarossi, Angela Prestifilippo, Gabriele Pizzino, Irene Paterniti, Emanuela Esposito, Anna Paola Capra. Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma. Cells 2024; 13(4): 361 doi: 10.3390/cells13040361
|
| 36 |
|
| 37 |
Sophie A. Dusoswa, Jan Verhoeff, Saskia van Asten, Joyce Lübbers, Marlous van den Braber, Sophie Peters, Sanne Abeln, Matheus H.W. Crommentuijn, Pieter Wesseling, William Peter Vandertop, Jos W. R. Twisk, Thomas Würdinger, David Noske, Yvette van Kooyk, Juan J. Garcia-Vallejo. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1343484
|
| 38 |
A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy. 2025; : 359 doi: 10.1002/9781119834090.ch7
|
| 39 |
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Gutiérrez-Arroyo, Alba Loras, Luis Gonzalez-Bonet, Conrado Martinez-Cadenas, José Estrela, María Marqués-Torrejón. Glioblastoma Therapy: Past, Present and Future. International Journal of Molecular Sciences 2024; 25(5): 2529 doi: 10.3390/ijms25052529
|
| 40 |
Sehar Ul Duaa, Eeshal Fatima, Zaheer Qureshi. Pamiparib, a novel intervention with anti-neoplastic activity for the treatment of glioblastoma. The American Journal of the Medical Sciences 2025; 369(1): 131 doi: 10.1016/j.amjms.2024.07.007
|
| 41 |
Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, Joseph C. Maroon, Dominic P. D’Agostino, Adrienne C. Scheck, Angela Poff, Sebastian F. Winter, Jethro Hu, Rainer J. Klement, Alicia Hickson, Derek C. Lee, Isabella Cooper, Barbara Kofler, Kenneth A. Schwartz, Matthew C. L. Phillips, Colin E. Champ, Beth Zupec-Kania, Jocelyn Tan-Shalaby, Fabiano M. Serfaty, Egiroh Omene, Gabriel Arismendi-Morillo, Michael Kiebish, Richard Cheng, Ahmed M. El-Sakka, Axel Pflueger, Edward H. Mathews, Donese Worden, Hanping Shi, Raffaele Ivan Cincione, Jean Pierre Spinosa, Abdul Kadir Slocum, Mehmet Salih Iyikesici, Atsuo Yanagisawa, Geoffrey J. Pilkington, Anthony Chaffee, Wafaa Abdel-Hadi, Amr K. Elsamman, Pavel Klein, Keisuke Hagihara, Zsófia Clemens, George W. Yu, Athanasios E. Evangeliou, Janak K. Nathan, Kris Smith, David Fortin, Jorg Dietrich, Purna Mukherjee, Thomas N. Seyfried. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03775-4
|
| 42 |
Nina Nelson, Angela Relógio. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock. npj Precision Oncology 2024; 8(1) doi: 10.1038/s41698-024-00530-z
|
| 43 |
Mervenur Yavuz, Turan Demircan. Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy. Toxicology and Applied Pharmacology 2024; 490: 117029 doi: 10.1016/j.taap.2024.117029
|
| 44 |
Inesa Navasardyan, Benjamin Bonavida. Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disorders. 2025; : 121 doi: 10.1016/B978-0-443-22354-9.00007-3
|
| 45 |
In Kang, Yumin Kim, Heung Kyu Lee. γδ T cells as a potential therapeutic agent for glioblastoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1273986
|
| 46 |
Tanner M. Johanns, Elizabeth A.R. Garfinkle, Katherine E. Miller, Alexandra J. Livingstone, Kaleigh F. Roberts, Lakshmi P. Rao Venkata, Joshua L. Dowling, Michael R. Chicoine, Ralph G. Dacey, Gregory J. Zipfel, Albert H. Kim, Elaine R. Mardis, Gavin P. Dunn. Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research 2024; 30(13): 2729 doi: 10.1158/1078-0432.CCR-23-3077
|
| 47 |
Gizzy Keeler, Stephenson B. Owusu, Mario Zanaty, Michael S. Petronek. Mitochondrial Iron Metabolism as a Potential Key Mediator of PD-L1 Thermal Regulation. Cancers 2024; 16(22): 3736 doi: 10.3390/cancers16223736
|